A-Rod releases statement denying the Miami New Times report

36 Comments

Alex Rodriguez has issued a statement in response to the report in the Miami New Times today in which patient records were released suggesting that he used performance enhancing drugs as recently as 2012:

“The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch’s patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story — at least as they relate to Alex Rodriguez — are not legitimate.”

This is a clear attack on the patient records released as unreliable.  Earlier, Major League Baseball released its own statement:

“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances.  These developments, however, provide evidence of the comprehensive nature of our anti-drug efforts.  Through our Department of Investigations, we have been actively involved in the issues in South Florida.  It is also important to note that three of the players allegedly involved have already been disciplined under the Joint Drug Program.

“The recommendations of the Mitchell Report have once again played a critical role in Major League Baseball’s ongoing efforts against performance-enhancing drugs.  MLB implemented all of the recommendations made by Senator Mitchell in 2007, several of which emphasized the significance of installing proactive investigative services.

“The establishment of our Department of Investigations has represented a critical advance in these comprehensive efforts.  In the years since its formation, DOI’s work has proven pivotal to bringing to light information regarding the use of performance-enhancing substances.  Furthermore, DOI has built strong working relationships with federal and local law enforcement authorities.  These relationships are crucial because only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs.

“Vigilance remains the key toward protecting the integrity of our game.  We have the best and most stringent drug testing policy in professional sports, we continue to work with our doctors and trainers to learn what they are seeing day-to-day and we educate our players about the game’s unbending zero-tolerance approach.  We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game.

“We are in the midst of an active investigation and are gathering and reviewing information.  We will refrain from further comment until this process is complete.”

With this, we are left with a he-said, he-said.  It will take more investigation by Major League Baseball and the DEA in order to determine what the significance is of the patient records reported on in the Miami New Times is, if any.

Cardinals move Luke Weaver to the bullpen

Luke Weaver
Getty Images
Leave a comment

Cardinals right-hander Luke Weaver has been reassigned to the bullpen, manager Mike Shildt announced Sunday. Fellow righty Daniel Poncedeleon will take his spot in the rotation for the time being, though it’s still unclear whether Weaver’s demotion is a permanent one or not.

Still, it’s not the most surprising of moves, especially as the club advances toward a potential playoff berth in October. Weaver, 24, has struggled to find his groove this season after putting up a 6-11 record in 24 starts and a 4.67 ERA, 3.2 BB/9 and 8.0 SO/9 over 125 1/3 innings in 2018. During two of his last three outings in August, he was pulled before the fifth inning, citing mechanical issues with his delivery that may be impacting his fastball location and delivery and having an adverse effect on his results — and those of the team — as well.

Poncedeleon, on the other hand, appears primed to take on more responsibility following an impressive run with the Cardinals this summer. He maintained a sub-3.00 ERA through his first six appearances, issuing four runs, nine walks, and 10 strikeouts over 17 2/3 innings. While he hasn’t handled more than one start in the big leagues, his track record in the minors speaks to his ability to get consistent results on the mound: he went 9-3 in 17 starts at Triple-A Memphis with a 2.15 ERA, 4.7 BB/9 and 10.1 SO/9 across 92 innings. He’s scheduled to cover for Weaver on Tuesday against the Pirates and will presumably continue to pitch out of the rotation for the remaining six weeks of the season.